Changing scenes after decade
نویسندگان
چکیده
منابع مشابه
Changing perspectives in yeast research nearly a decade after the genome sequence.
Research with budding yeast (Saccharomyces cerevisiae) has been transformed by the publication, nearly a decade ago, of the entire genome DNA sequence. The introduction of this first eukaryotic genomic sequence changed the yeast research environment significantly, not just because of dramatic progress in technical means but also because the sequence made accessible a new class of scientific que...
متن کاملGhrelin discovery: a decade after.
Since its discovery 12 years ago, intensive research has been performed on ghrelin. The significance of ghrelin as a growth hormone-releasing hormone, appetite regulator, energy conservator and sympathetic nerve suppressor has now been well established. In this short essay, we summarize the history of the discovery of ghrelin.
متن کاملParents of Psychiatrically Hospitalized Children: A Decade of Changing Perceptions
When a child is hospitalized on a psychiatric unit, the parents are crucial to the evaluation and treatment of that child. While the importance of parents to their child's inpatient treatment may seem obvious, it is a topic which has been surprisingly rare in recent literature, and certainly warrants further empirical study (Blotcky et al., 1984). During the last decade, I have been a social wo...
متن کاملAdolescent Pregnancy and the Changing Landscape during the past Decade
Teen pregnancy and parenting remain an important public health issue in the United States and the world, and many children live with their adolescent parents alone or as part of an extended family. A significant proportion of teen parents reside with their family of origin, significantly affecting the multigenerational family structure. Repeated births to teen parents are also common. This clin...
متن کاملAurer 1 CHANGING THERAPEUTIC LANDSCAPE – THE LAST DECADE
Undoubtedly the most important event in the previous decade in lymphoma treatment was the establishment of immunotherapy as a prime modality. Addition of rituximab improves survival in almost every group of patients with CD20+ tumors. This has led to the appearance of a number of “me too” monoclonal antibodies (MoAbs) as well as MoAbs directed against other antigens whose usefulness remains to ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Acta Obstetricia et Gynecologica Scandinavica
سال: 2009
ISSN: 0001-6349,1600-0412
DOI: 10.3109/00016340903477864